As we come to the end of the long summer of 2020, we’ve now been dealing with the COVID-19 pandemic for roughly six months here in the United States. We still don’t know when it will end. Vaccines and treatments are under development, but when they will be available remains uncertain.
In the meantime, cancer isn’t going away. And delays in treatment that occurred early on may be part of the collateral damage from this pandemic. Continue reading